{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T20:25:36Z","timestamp":1787084736779,"version":"build-2736575974"},"reference-count":273,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100023296","name":"Alleanza Contro il Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023296","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jacc.2026.05.032","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:21:42Z","timestamp":1786994502000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["2026 AHA\/ACC Clinical Performance and Quality Measures for Patients With Atrial Fibrillation"],"prefix":"10.1016","author":[{"given":"Emelia J.","family":"Benjamin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory M.","family":"Marcus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul L.","family":"Hess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Addison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Akar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas K.","family":"Brownell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice Y.","family":"Chyou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine G.","family":"Derington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca L.","family":"Diekemper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Frankel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gene S.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinwe","family":"Ibeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"Larry R.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen E.","family":"Joynt Maddox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan Reading","family":"Turchioe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Tisdale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunice","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2026.05.032_bib1","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.jacc.2010.09.009","article-title":"ACCF\/AHA new insights into the methodology of performance measurement: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Performance Measures","volume":"56","author":"Spertus","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib2","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.jacc.2005.03.011","article-title":"American College of Cardiology and American Heart Association methodology for the selection and creation of performance measures for quantifying the quality of cardiovascular care","volume":"45","author":"Spertus","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib3","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jacc.2020.08.037","article-title":"2020 Update to the 2016 ACC\/AHA clinical performance and quality measures for adults with atrial fibrillation or atrial flutter: a report of the American College of Cardiology\/American Heart Association Task Force on Performance Measures","volume":"77","author":"Heidenreich","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib4","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jacc.2016.03.521","article-title":"2016 ACC\/AHA clinical performance and quality measures for adults with atrial fibrillation or atrial flutter: a report of the American College of Cardiology\/American Heart Association Task Force on Performance Measures","volume":"68","author":"Heidenreich","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jacc.2023.08.017","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"83","author":"Joglar","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib6","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1001\/jamacardio.2024.2969","article-title":"Hospital heart failure medical therapy score and associated clinical outcomes and costs","volume":"9","author":"Polsinelli","year":"2024","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib7","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.125.012936","article-title":"Get With The Guidelines-heart failure: twenty years in review, lessons learned, and the road ahead","volume":"18","author":"Tang","year":"2025","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2026.05.032_bib8","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1161\/STROKEAHA.124.048174","article-title":"Twenty years of sustained improvement in quality of care and outcomes for patients hospitalized with stroke or transient ischemic attack: data from the Get With The Guidelines-Stroke Program","volume":"55","author":"Xian","year":"2024","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2026.05.032_bib9","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.jacc.2024.07.014","article-title":"Minimum national prevalence of diagnosed atrial fibrillation inferred from California acute care facilities","volume":"84","author":"Noubiap","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib10","article-title":"Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study","volume":"361","author":"Staerk","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2026.05.032_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-077209","article-title":"Temporal trends in lifetime risks of atrial fibrillation and its complications between 2000 and 2022: Danish, nationwide, population based cohort study","volume":"385","author":"Vinter","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2026.05.032_bib12","first-page":"e41","article-title":"2025 heart disease and stroke statistics: a report of US and global data from the American Heart Association","volume":"151","author":"Martin","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2026.05.032_bib13","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.hroo.2022.07.010","article-title":"Healthcare utilization and costs associated with a diagnosis of incident atrial fibrillation","volume":"3","author":"Deshmukh","year":"2022","journal-title":"Heart Rhythm O2"},{"key":"10.1016\/j.jacc.2026.05.032_bib14","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1001\/jama.2020.0734","article-title":"US health care spending by payer and health condition, 1996-2016","volume":"323","author":"Dieleman","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2026.05.032_bib15","article-title":"Atrial fibrillation as risk factor for cardiovascular disease and death in women compared with men: systematic review and meta-analysis of cohort studies","volume":"532","author":"Emdin","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2026.05.032_bib16","article-title":"Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis","volume":"354","author":"Odutayo","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2026.05.032_bib17","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1007\/s11606-021-06954-8","article-title":"Atrial fibrillation is associated with cognitive impairment, all-cause dementia, vascular dementia, and Alzheimer's disease: a systematic review and meta-analysis","volume":"36","author":"Papanastasiou","year":"2021","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jacc.2026.05.032_bib18","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1177\/2047487317715769","article-title":"Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: a systematic review and meta-analysis","volume":"24","author":"Ruddox","year":"2017","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10840-017-0308-9","article-title":"Atrial fibrillation is associated with sudden cardiac death: a systematic review and meta-analysis","volume":"51","author":"Rattanawong","year":"2018","journal-title":"J Interv Card Electrophysiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib20","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.hrthm.2024.03.010","article-title":"Systemic infarcts among patients with atrial fibrillation","volume":"21","author":"Cabulong","year":"2024","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2026.05.032_bib21","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/eurheartj\/eht483","article-title":"Clinical course of atrial fibrillation in older adults: the importance of cardiovascular events beyond stroke","volume":"35","author":"Piccini","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2026.05.032_bib22","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.1016\/j.cjco.2021.09.004","article-title":"Racial and ethnic differences in the management of atrial fibrillation","volume":"3","author":"Tamirisa","year":"2021","journal-title":"CJC Open"},{"key":"10.1016\/j.jacc.2026.05.032_bib23","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/ehjqcco\/qcz053","article-title":"Socioeconomic differences in outcomes after hospital admission for atrial fibrillation or flutter","volume":"7","author":"Hagengaard","year":"2021","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.jacc.2026.05.032_bib24","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1080\/14779072.2018.1533118","article-title":"Associations between socioeconomic status, atrial fibrillation, and outcomes: a systematic review","volume":"16","author":"Lunde","year":"2018","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.jacc.2026.05.032_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amjcard.2025.02.028","article-title":"Meta-analysis of racial and ethnic disparities in rhythm control strategies for atrial fibrillation in the United States","volume":"245","author":"Moinul","year":"2025","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib26","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euaf027","article-title":"Global, regional, and national burden of atrial fibrillation and atrial flutter from 1990 to 2021: sex differences and global burden projections to 2046: a systematic analysis of the Global Burden of Disease Study 2021","volume":"27","author":"Tan","year":"2025","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2026.05.032_bib27","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/S2468-2667(25)00260-9","article-title":"Temporal trends in associations between social drivers and life-years lost in newly diagnosed atrial fibrillation in Denmark, 2000-22: a nationwide cohort study","volume":"11","author":"Vinter","year":"2026","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.jacc.2026.05.032_bib28","article-title":"Treatment timing and the effects of rhythm control strategy in patients with atrial fibrillation: nationwide cohort study","volume":"373","author":"Kim","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2026.05.032_bib29","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/intqhc\/10.3.247","article-title":"Eliciting expert opinion using the Delphi technique: identifying performance indicators for cardiovascular disease","volume":"10","author":"Normand","year":"1998","journal-title":"Int J Qual Health Care"},{"key":"10.1016\/j.jacc.2026.05.032_bib30","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/j.jacc.2018.01.004","article-title":"2018 ACC\/AHA clinical performance and quality measures for cardiac rehabilitation: a report of the American College of Cardiology\/American Heart Association Task Force on Performance Measures","volume":"71","author":"Thomas","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib31","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1001\/jamacardio.2022.4091","article-title":"Transforming atrial fibrillation research to integrate social determinants of health: a National Heart, Lung, and Blood Institute Workshop Report","volume":"8","author":"Benjamin","year":"2023","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib32","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1161\/01.CIR.0000068313.67758.4F","article-title":"Longitudinal myocardial function assessed by tissue velocity, strain, and strain rate tissue Doppler echocardiography in patients with AL (primary) cardiac amyloidosis","volume":"107","author":"Koyama","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2026.05.032_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155581","article-title":"Chronic kidney disease and the risk of new-onset atrial fibrillation: a meta-analysis of prospective cohort studies","volume":"11","author":"Shang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2026.05.032_bib34","article-title":"Link between non-alcoholic fatty liver disease and atrial fibrillation: a systematic review and meta-analysis","volume":"9","author":"Minhas","year":"2017","journal-title":"Cureus"},{"key":"10.1016\/j.jacc.2026.05.032_bib35","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1001\/archinte.164.15.1675","article-title":"Hyperthyroidism and risk of atrial fibrillation or flutter: a population-based study","volume":"164","author":"Frost","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2026.05.032_bib36","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1161\/CIRCULATIONAHA.106.678326","article-title":"Thyroid disease and the heart","volume":"116","author":"Klein","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2026.05.032_bib37","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.jacc.2007.05.035","article-title":"The value of myocardial perfusion single-photon emission computed tomography in screening asymptomatic patients with atrial fibrillation for coronary artery disease","volume":"50","author":"Askew","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib38","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1001\/jamainternmed.2015.4802","article-title":"Low yield of myocardial perfusion imaging in asymptomatic patients with atrial fibrillation","volume":"175","author":"Cremer","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2026.05.032_bib39","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1538-7836.2011.04608.x","article-title":"Is atrial fibrillation associated with pulmonary embolism?","volume":"10","author":"Gex","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jacc.2026.05.032_bib40","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijcard.2015.01.060","article-title":"Left atrial volume is more important than the type of atrial fibrillation in predicting the long-term success of catheter ablation","volume":"184","author":"Costa","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib41","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/echo.13184","article-title":"Clinical relevance of left atrial strain to predict recurrence of atrial fibrillation after catheter ablation: a meta-analysis","volume":"33","author":"Ma","year":"2016","journal-title":"Echocardiography"},{"key":"10.1016\/j.jacc.2026.05.032_bib42","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.jacc.2020.07.009","article-title":"Atrial dysfunction in patients with heart failure with preserved ejection fraction and atrial fibrillation","volume":"76","author":"Reddy","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib43","first-page":"139","article-title":"Obesity and the risk of incident, post-operative, and post-ablation atrial fibrillation: a meta-analysis of 626,603 individuals in 51 studies","volume":"1","author":"Wong","year":"2015","journal-title":"J Am Coll Cardiol EP"},{"key":"10.1016\/j.jacc.2026.05.032_bib44","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.hrthm.2012.08.043","article-title":"Obesity results in progressive atrial structural and electrical remodeling: implications for atrial fibrillation","volume":"10","author":"Abed","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2026.05.032_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2015.04.058","article-title":"Electrophysiological, electroanatomical, and structural remodeling of the atria as consequences of sustained obesity","volume":"66","author":"Mahajan","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib46","first-page":"630","article-title":"Atrial fibrillation and obesity: reverse remodeling of atrial substrate with weight reduction","volume":"7","author":"Mahajan","year":"2021","journal-title":"J Am Coll Cardiol EP"},{"key":"10.1016\/j.jacc.2026.05.032_bib47","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/heartjnl-2018-313490","article-title":"Impact of body mass index on the outcome of catheter ablation of atrial fibrillation","volume":"105","author":"Glover","year":"2019","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2026.05.032_bib48","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012253","article-title":"Impact of body mass index on the outcomes of catheter ablation of atrial fibrillation: a European observational multicenter study","volume":"8","author":"Provid\u00eancia","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2026.05.032_bib49","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1161\/CIRCULATIONAHA.115.018220","article-title":"Aerobic interval training reduces the burden of atrial fibrillation in the short term: a randomized trial","volume":"133","author":"Malmo","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2026.05.032_bib50","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ijcard.2006.03.034","article-title":"Effects of short-term exercise training on symptoms and quality of life in patients with chronic atrial fibrillation","volume":"116","author":"Hegbom","year":"2007","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib51","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.ahj.2011.09.013","article-title":"A randomized study of the effects of exercise training on patients with atrial fibrillation","volume":"162","author":"Osbak","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2026.05.032_bib52","first-page":"455","article-title":"An exercise and physical activity program in patients with atrial fibrillation: the ACTIVE-AF randomized controlled trial","volume":"9","author":"Elliott","year":"2023","journal-title":"J Am Coll Cardiol EP"},{"key":"10.1016\/j.jacc.2026.05.032_bib53","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1136\/tobaccocontrol-2011-050124","article-title":"Who receives prescriptions for smoking cessation medications? An association rule mining analysis using a large primary care database","volume":"22","author":"Huang","year":"2013","journal-title":"Tob Control"},{"key":"10.1016\/j.jacc.2026.05.032_bib54","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011307","article-title":"Provider-level variation in smoking cessation assistance provided in the cardiology clinics: insights from the NCDR PINNACLE registry","volume":"8","author":"Sardana","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2026.05.032_bib55","first-page":"CD000165","article-title":"Physician advice for smoking cessation","volume":"2013","author":"Stead","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2026.05.032_bib56","article-title":"Behavioural interventions for smoking cessation: an overview and network meta-analysis","volume":"1","author":"Hartmann-Boyce","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2026.05.032_bib57","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.115.002458","article-title":"Efficacy and safety of smoking cessation interventions in patients with cardiovascular disease: a network meta-analysis of randomized controlled trials","volume":"10","author":"Suissa","year":"2017","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2026.05.032_bib58","doi-asserted-by":"crossref","first-page":"608","DOI":"10.7326\/M15-0171","article-title":"Behavioral counseling and pharmacotherapy interventions for tobacco cessation in adults, including pregnant women: a review of reviews for the U.S. Preventive Services Task Force","volume":"163","author":"Patnode","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2026.05.032_bib59","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1817591","article-title":"Alcohol abstinence in drinkers with atrial fibrillation","volume":"382","author":"Voskoboinik","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2026.05.032_bib60","first-page":"662","article-title":"A randomized, double-blind, placebo-controlled trial of intravenous alcohol to assess changes in atrial electrophysiology","volume":"7","author":"Marcus","year":"2021","journal-title":"J Am Coll Cardiol EP"},{"key":"10.1016\/j.jacc.2026.05.032_bib61","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/jamacardio.2021.5010","article-title":"Individualized studies of triggers of paroxysmal atrial fibrillation: the I-STOP-AFib randomized clinical trial","volume":"7","author":"Marcus","year":"2022","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib62","first-page":"1187","article-title":"The atrial fibrillation therapies after ER visit: outpatient care for patients with acute AF - the AFTER3 study","volume":"7","author":"Angaran","year":"2015","journal-title":"J Atr Fibrillation"},{"key":"10.1016\/j.jacc.2026.05.032_bib63","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.jacc.2020.01.052","article-title":"Mobile health technology to improve care for patients with atrial fibrillation","volume":"75","author":"Guo","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib64","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1093\/eurheartj\/ehx739","article-title":"Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation: results of the RACE 3 trial","volume":"39","author":"Rienstra","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2026.05.032_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003599","article-title":"Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: an individual participant data meta-analysis","volume":"18","author":"Pinho-Gomes","year":"2021","journal-title":"PLoS Med"},{"key":"10.1016\/j.jacc.2026.05.032_bib66","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1001\/jama.2013.280521","article-title":"Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial","volume":"310","author":"Abed","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2026.05.032_bib67","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1093\/europace\/euy117","article-title":"PREVEntion and regReSsive Effect of weight-loss and risk factor modification on Atrial Fibrillation: the REVERSE-AF study","volume":"20","author":"Middeldorp","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2026.05.032_bib68","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.jacc.2014.09.028","article-title":"Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study","volume":"64","author":"Pathak","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib69","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.jacc.2015.03.002","article-title":"Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY)","volume":"65","author":"Pathak","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib70","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/HCR.0000000000000665","article-title":"Effects of supervised exercise training on atrial fibrillation: a meta-analysis of randomized controlled trials","volume":"42","author":"Oesterle","year":"2022","journal-title":"J Cardiopulm Rehabil Prev"},{"key":"10.1016\/j.jacc.2026.05.032_bib71","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jacc.2015.06.488","article-title":"Impact of CARDIOrespiratory FITness on arrhythmia recurrence in obese individuals with atrial fibrillation the CARDIO-FIT study","volume":"66","author":"Pathak","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib72","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.jacc.2019.03.009","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"74","author":"Arnett","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib73","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/cvr\/cvaa344","article-title":"Stroke risk prediction in patients with atrial fibrillation with and without rheumatic heart disease","volume":"118","author":"Benz","year":"2022","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacc.2026.05.032_bib74","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ahj.2016.11.008","article-title":"Multimorbidity and the risk of hospitalization and death in atrial fibrillation: a population-based study","volume":"185","author":"Chamberlain","year":"2017","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2026.05.032_bib75","first-page":"552","article-title":"Modifiable risk factors for incident heart failure in atrial fibrillation","volume":"5","author":"Chatterjee","year":"2017","journal-title":"J Am Coll Cardiol HF"},{"key":"10.1016\/j.jacc.2026.05.032_bib76","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12889-020-8275-y","article-title":"Association of smoking cessation after atrial fibrillation diagnosis on the risk of cardiovascular disease: a cohort study of South Korean men","volume":"20","author":"Choi","year":"2020","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jacc.2026.05.032_bib77","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijcard.2016.12.029","article-title":"Aldosterone pathway blockade to prevent atrial fibrillation: a systematic review and meta-analysis","volume":"231","author":"Neefs","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib78","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002197","article-title":"Cause of death and predictors of all-cause mortality in anticoagulated patients with nonvalvular atrial fibrillation: data from ROCKET AF","volume":"5","author":"Pokorney","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2026.05.032_bib79","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002015","article-title":"Blood pressure control and risk of stroke or systemic embolism in patients with atrial fibrillation: results from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial","volume":"4","author":"Rao","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2026.05.032_bib80","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1001\/jama.2019.21187","article-title":"Effect of renal denervation and catheter ablation vs catheter ablation alone on atrial fibrillation recurrence among patients with paroxysmal atrial fibrillation and hypertension: the ERADICATE-AF randomized clinical trial","volume":"323","author":"Steinberg","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2026.05.032_bib81","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1161\/01.STR.27.10.1760","article-title":"Stroke severity in atrial fibrillation. The Framingham Study","volume":"27","author":"Lin","year":"1996","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2026.05.032_bib82","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1161\/CIRCEP.109.849638","article-title":"The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study","volume":"2","author":"Glotzer","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib83","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1161\/01.CIR.0000057981.70380.45","article-title":"Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST)","volume":"107","author":"Glotzer","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2026.05.032_bib84","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.amjcard.2012.06.034","article-title":"Detection of previously undiagnosed atrial fibrillation in patients with stroke risk factors and usefulness of continuous monitoring in primary stroke prevention","volume":"110","author":"Ziegler","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib85","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1161\/STROKEAHA.109.571455","article-title":"Incidence of newly detected atrial arrhythmias via implantable devices in patients with a history of thromboembolic events","volume":"41","author":"Ziegler","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2026.05.032_bib86","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-017157","article-title":"Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation","volume":"7","author":"Fox","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.jacc.2026.05.032_bib87","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2026.05.032_bib88","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000250","article-title":"A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score","volume":"2","author":"Singer","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2026.05.032_bib89","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1161\/CIRCULATIONAHA.116.024057","article-title":"Wide variation in reported rates of stroke across cohorts of patients with atrial fibrillation","volume":"135","author":"Quinn","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2026.05.032_bib90","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2026.05.032_bib91","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2026.05.032_bib92","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2026.05.032_bib93","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2026.05.032_bib94","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2026.05.032_bib95","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1161\/CIRCULATIONAHA.121.056355","article-title":"Direct oral anticoagulants versus warfarin in patients with atrial fibrillation: patient-level network meta-analyses of randomized clinical trials with interaction testing by age and sex","volume":"145","author":"Carnicelli","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2026.05.032_bib96","article-title":"Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis","volume":"359","author":"Lopez-Lopez","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2026.05.032_bib97","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2026.05.032_bib98","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1093\/eurheartj\/ehw077","article-title":"Comparison of the ATRIA, CHADS2, and CHA2DS2-VASc stroke risk scores in predicting ischaemic stroke in a large Swedish cohort of patients with atrial fibrillation","volume":"37","author":"Aspberg","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2026.05.032_bib99","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2026.05.032_bib100","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1161\/CIRCOUTCOMES.110.958108","article-title":"Moving the tipping point","volume":"4","author":"Eckman","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2026.05.032_bib101","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1016\/j.jacc.2020.08.044","article-title":"2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"76","author":"Ommen","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib102","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(06)68845-4","article-title":"Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial","volume":"367","author":"Connolly","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2026.05.032_bib103","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1056\/NEJMoa1109867","article-title":"Dronedarone in high-risk permanent atrial fibrillation","volume":"365","author":"Connolly","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2026.05.032_bib104","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1161\/01.STR.0000198839.61112.ee","article-title":"Low-dose aspirin for prevention of stroke in low-risk patients with atrial fibrillation: Japan Atrial Fibrillation Stroke trial","volume":"37","author":"Sato","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2026.05.032_bib105","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1046\/j.1460-9592.2003.00042.x","article-title":"Thromboembolic risk of patients referred for radiofrequency catheter ablation of typical atrial flutter without prior appropriate anticoagulation therapy","volume":"26","author":"Gronefeld","year":"2003","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib106","first-page":"774","article-title":"Elevated incidence of atrial fibrillation and stroke in patients with atrial flutter: a population-based study","volume":"34","author":"Gula","year":"2018","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib107","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1136\/heartjnl-2015-307550","article-title":"Atrial flutter and thromboembolic risk: a systematic review","volume":"101","author":"Vadmann","year":"2015","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2026.05.032_bib108","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa1708454","article-title":"Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation","volume":"377","author":"Cannon","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2026.05.032_bib109","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1056\/NEJMoa1611594","article-title":"Prevention of bleeding in patients with atrial fibrillation undergoing PCI","volume":"375","author":"Gibson","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2026.05.032_bib110","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1817083","article-title":"Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation","volume":"380","author":"Lopes","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2026.05.032_bib111","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/europace\/euz259","volume":"22","author":"Potpara","year":"2020","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2026.05.032_bib112","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0140-6736(19)31872-0","article-title":"Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial","volume":"394","author":"Vranckx","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2026.05.032_bib113","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(12)62177-1","article-title":"Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial","volume":"381","author":"Dewilde","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2026.05.032_bib114","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.hrthm.2015.03.031","article-title":"Race- and sex-related differences in care for patients newly diagnosed with atrial fibrillation","volume":"12","author":"Bhave","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2026.05.032_bib115","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.005801","article-title":"Sex differences in the use of oral anticoagulants for atrial fibrillation: a report from the National Cardiovascular Data Registry (NCDR(\u00ae)) PINNACLE registry","volume":"6","author":"Thompson","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2026.05.032_bib116","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1016\/j.hrthm.2015.06.029","article-title":"Temporal trends and sex differences in pulmonary vein isolation for patients with atrial fibrillation","volume":"12","author":"Avgil Tsadok","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2026.05.032_bib117","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.amjcard.2016.01.040","article-title":"Gender, race, and health insurance status in patients undergoing catheter ablation for atrial fibrillation","volume":"117","author":"Patel","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib118","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.hrthm.2018.05.019","article-title":"Racial and ethnic differences in the prevalence, management, and outcomes in patients with atrial fibrillation: a systematic review","volume":"15","author":"Ugowe","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2026.05.032_bib119","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.amepre.2017.05.011","article-title":"A systematic review of interventions on patients' social and economic needs","volume":"53","author":"Gottlieb","year":"2017","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.jacc.2026.05.032_bib120","doi-asserted-by":"crossref","first-page":"e841","DOI":"10.1161\/CIR.0000000000000767","article-title":"Addressing social determinants of health in the care of patients with heart failure: a scientific statement from the American Heart Association","volume":"141","author":"White-Williams","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2026.05.032_bib121","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/M20-0730","article-title":"Developing primary care-based recommendations for social determinants of health: methods of the U.S. Preventive Services Task Force","volume":"173","author":"Davidson","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2026.05.032_bib122","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1001\/jama.2021.12833","article-title":"Incorporation of social risk in US Preventive Services Task Force recommendations and identification of key challenges for primary care","volume":"326","author":"Davidson","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2026.05.032_bib123","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1111\/jce.14838","article-title":"Women and atrial fibrillation","volume":"32","author":"Volgman","year":"2021","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib124","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1111\/jce.14758","article-title":"Sex-based differences in procedural complications associated with atrial fibrillation catheter ablation: a systematic review and meta-analysis","volume":"31","author":"Campbell","year":"2020","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib125","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1161\/CIRCULATIONAHA.120.051558","article-title":"Association between sex and treatment outcomes of atrial fibrillation ablation versus drug therapy: results from the CABANA trial","volume":"143","author":"Russo","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2026.05.032_bib126","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","article-title":"Early rhythm-control therapy in patients with atrial fibrillation","volume":"383","author":"Kirchhof","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2026.05.032_bib127","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jacc.2021.04.092","article-title":"Ablation versus drug therapy for atrial fibrillation in racial and ethnic minorities","volume":"78","author":"Thomas","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib128","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1161\/CIRCULATIONAHA.122.058949","article-title":"Association of neighborhood-level material deprivation with atrial fibrillation care in a single-payer health care system: a population-based cohort study","volume":"146","author":"Abdel-Qadir","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2026.05.032_bib129","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.961","article-title":"Association of income and educational levels with adherence to direct oral anticoagulant therapy in patients with incident atrial fibrillation: a Finnish nationwide cohort study","volume":"10","author":"Teppo","year":"2022","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.jacc.2026.05.032_bib130","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.amjcard.2018.04.022","article-title":"Influence of sociodemographic factors and provider specialty on anticoagulation prescription fill patterns and outcomes in atrial fibrillation","volume":"122","author":"O'Neal","year":"2018","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib131","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.0247","article-title":"Racial\/ethnic and socioeconomic disparities in management of incident paroxysmal atrial fibrillation","volume":"4","author":"Eberly","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacc.2026.05.032_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2021.100201","article-title":"Association of income and educational attainment in hospitalization events in atrial fibrillation","volume":"7","author":"Tertulien","year":"2021","journal-title":"Am J Prev Cardiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib133","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1136\/heartjnl-2019-316065","article-title":"Association of household income and adverse outcomes in patients with atrial fibrillation","volume":"106","author":"LaRosa","year":"2020","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2026.05.032_bib134","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.amjcard.2018.11.045","article-title":"Comparison of baseline characteristics and in-hospital outcomes in Medicaid versus private insurance hospitalizations for atrial fibrillation","volume":"123","author":"Doshi","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib135","doi-asserted-by":"crossref","first-page":"e615","DOI":"10.1161\/CIR.0000000000000753","article-title":"Call to action: rural health: a presidential advisory from the American Heart Association and American Stroke Association","volume":"141","author":"Harrington","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2026.05.032_bib136","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1056\/NEJMoa2101897","article-title":"Left atrial appendage occlusion during cardiac surgery to prevent stroke","volume":"384","author":"Whitlock","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2026.05.032_bib137","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/jama.2017.20125","article-title":"Association between left atrial appendage occlusion and readmission for thromboembolism among patients with atrial fibrillation undergoing concomitant cardiac surgery","volume":"319","author":"Friedman","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2026.05.032_bib138","first-page":"252","article-title":"Beneficial effect of left atrial appendage closure during cardiac surgery: a meta-analysis of 280 585 patients","volume":"57","author":"Mart\u00edn Guti\u00e9rrez","year":"2020","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jacc.2026.05.032_bib139","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1056\/NEJMoa1904143","article-title":"Antithrombotic therapy for atrial fibrillation with stable coronary disease","volume":"381","author":"Yasuda","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2026.05.032_bib140","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1056\/NEJMoa2407362","article-title":"Edoxaban antithrombotic therapy for atrial fibrillation and stable coronary artery disease","volume":"391","author":"Cho","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2026.05.032_bib141","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.jacc.2024.12.030","article-title":"Anticoagulation and antiplatelet therapy for atrial fibrillation and stable coronary disease: meta-analysis of randomized trials","volume":"85","author":"Rashedi","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib142","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJMoa2507532","article-title":"Aspirin in patients with chronic coronary syndrome receiving oral anticoagulation","volume":"393","author":"Lemesle","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2026.05.032_bib143","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1016\/j.jcin.2021.07.045","article-title":"Rivaroxaban monotherapy in patients with atrial fibrillation after coronary stenting: insights from the AFIRE trial","volume":"14","author":"Matoba","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2026.05.032_bib144","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1161\/CIRCULATIONAHA.118.036768","article-title":"Open-label randomized trial comparing oral anticoagulation with and without single antiplatelet therapy in patients with atrial fibrillation and stable coronary artery disease beyond 1 year after coronary stent implantation","volume":"139","author":"Matsumura-Nakano","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2026.05.032_bib145","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society","volume":"64","author":"January","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib146","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.ahj.2012.03.011","article-title":"A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves: the randomized, phase II study to evaluate the safety and pharmacokinetics of oral dabigatran etexilate in patients after heart valve replacement (RE-ALIGN)","volume":"163","author":"Van de Werf","year":"2012","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2026.05.032_bib147","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jacc.2019.01.011","volume":"74","author":"January","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib148","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1056\/NEJMoa2209051","article-title":"Rivaroxaban in rheumatic heart disease-associated atrial fibrillation","volume":"387","author":"Connolly","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2026.05.032_bib149","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1177\/1060028020970618","article-title":"Off-label use for direct oral anticoagulants: valvular atrial fibrillation, heart failure, left ventricular thrombus, superficial vein thrombosis, pulmonary hypertension: a systematic review","volume":"55","author":"Brokmeier","year":"2021","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jacc.2026.05.032_bib150","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1161\/CIRCULATIONAHA.116.026793","article-title":"Direct oral anticoagulants in patients with atrial fibrillation and valvular heart disease other than significant mitral stenosis and mechanical valves: a meta-analysis","volume":"135","author":"Siontis","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2026.05.032_bib151","series-title":"Savaysa [package insert]","year":"2015"},{"key":"10.1016\/j.jacc.2026.05.032_bib152","series-title":"Ingelheim am Rhein","year":"2011"},{"key":"10.1016\/j.jacc.2026.05.032_bib153","series-title":"Beerse, Belgium","year":"2022"},{"key":"10.1016\/j.jacc.2026.05.032_bib154","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/jcph.628","article-title":"Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end-stage renal disease on hemodialysis","volume":"56","author":"Wang","year":"2016","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jacc.2026.05.032_bib155","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1681\/ASN.2016090980","article-title":"Apixaban pharmacokinetics at steady state in hemodialysis patients","volume":"28","author":"Mavrakanas","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jacc.2026.05.032_bib156","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1161\/CIRCULATIONAHA.118.035418","article-title":"Outcomes associated with apixaban use in patients with end-stage kidney disease and atrial fibrillation in the United States","volume":"138","author":"Siontis","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2026.05.032_bib157","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.2215\/CJN.11650919","article-title":"Apixaban versus no anticoagulation in patients undergoing long-term dialysis with incident atrial fibrillation","volume":"15","author":"Mavrakanas","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jacc.2026.05.032_bib158","doi-asserted-by":"crossref","first-page":"181","DOI":"10.7326\/M19-0087","article-title":"Benefits and harms of oral anticoagulant therapy in chronic kidney disease: a systematic review and meta-analysis","volume":"171","author":"Ha","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2026.05.032_bib159","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.2215\/CJN.02400311","article-title":"Warfarin in atrial fibrillation patients with moderate chronic kidney disease","volume":"6","author":"Hart","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jacc.2026.05.032_bib160","article-title":"Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease","volume":"11","author":"Kimachi","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2026.05.032_bib161","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1001\/jama.2014.1334","article-title":"Warfarin, kidney dysfunction, and outcomes following acute myocardial infarction in patients with atrial fibrillation","volume":"311","author":"Carrero","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2026.05.032_bib162","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1161\/CIRCULATIONAHA.119.044059","article-title":"Apixaban versus warfarin in patients with atrial fibrillation and advanced chronic kidney disease","volume":"141","author":"Stanifer","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2026.05.032_bib163","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1016\/j.jacc.2014.09.051","article-title":"Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study","volume":"64","author":"Bonde","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib164","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.2175","article-title":"Association between use of warfarin for atrial fibrillation and outcomes among patients with end-stage renal disease: a systematic review and meta-analysis","volume":"3","author":"Randhawa","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacc.2026.05.032_bib165","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1056\/NEJMoa021328","article-title":"A comparison of rate control and rhythm control in patients with atrial fibrillation","volume":"347","author":"Wyse","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2026.05.032_bib166","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1378\/chest.126.2.476","article-title":"Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish how to treat chronic atrial fibrillation (HOT CAFE) study","volume":"126","author":"Opolski","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2026.05.032_bib167","doi-asserted-by":"crossref","first-page":"760","DOI":"10.7326\/M13-1467","article-title":"Rate- and rhythm-control therapies in patients with atrial fibrillation: a systematic review","volume":"160","author":"Al-Khatib","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2026.05.032_bib168","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJMoa1001337","article-title":"Lenient versus strict rate control in patients with atrial fibrillation","volume":"362","author":"Van Gelder","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2026.05.032_bib169","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1161\/CIRCULATIONAHA.111.019919","article-title":"Rate control in atrial fibrillation: targets, methods, resynchronization considerations","volume":"124","author":"Heist","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2026.05.032_bib170","doi-asserted-by":"crossref","first-page":"e676","DOI":"10.1161\/CIR.0000000000001133","article-title":"Atrial fibrillation occurring during acute hospitalization: a scientific statement from the American Heart Association","volume":"147","author":"Chyou","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2026.05.032_bib171","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.annemergmed.2014.09.012","article-title":"Emergency department patients with atrial fibrillation or flutter and an acute underlying medical illness may not benefit from attempts to control rate or rhythm","volume":"65","author":"Scheuermeyer","year":"2015","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jacc.2026.05.032_bib172","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/0002-9343(64)90160-3","article-title":"Hemodynamic consequences of atrial fibrillation at constant ventricular rates","volume":"36","author":"Skinner","year":"1964","journal-title":"Am J Med"},{"issue":"Suppl 1","key":"10.1016\/j.jacc.2026.05.032_bib173","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000047278","article-title":"Calcium channel blockers in heart failure","volume":"89","author":"Elkayam","year":"1998","journal-title":"Cardiology"},{"key":"10.1016\/j.jacc.2026.05.032_bib174","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jemermed.2015.01.014","article-title":"Diltiazem vs. metoprolol in the management of atrial fibrillation or flutter with rapid ventricular rate in the emergency department","volume":"49","author":"Fromm","year":"2015","journal-title":"J Emerg Med"},{"key":"10.1016\/j.jacc.2026.05.032_bib175","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ajem.2021.08.082","article-title":"Intravenous diltiazem versus metoprolol for atrial fibrillation with rapid ventricular rate: a meta-analysis","volume":"51","author":"Lan","year":"2022","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jacc.2026.05.032_bib176","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/0002-9149(89)90141-0","article-title":"Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter","volume":"63","author":"Platia","year":"1989","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib177","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ajem.2022.03.058","article-title":"Acute management of atrial fibrillation in congestive heart failure with reduced ejection fraction in the emergency department","volume":"58","author":"Hasbrouck","year":"2022","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jacc.2026.05.032_bib178","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s40261-018-0631-7","article-title":"Safety of intravenous diltiazem in reduced ejection fraction heart failure with rapid atrial fibrillation","volume":"38","author":"Jandali","year":"2018","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.jacc.2026.05.032_bib179","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1056\/NEJM198908103210629","article-title":"Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction","volume":"321","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2026.05.032_bib180","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM199103213241201","article-title":"Mortality and morbidity in patients receiving encainide, flecainide, or placebo: the Cardiac Arrhythmia Suppression trial","volume":"324","author":"Echt","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2026.05.032_bib181","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1056\/NEJM199207233270403","article-title":"Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction","volume":"327","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2026.05.032_bib182","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1161\/01.CIR.102.7.748","article-title":"Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH)","volume":"102","author":"Kuck","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2026.05.032_bib183","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1056\/NEJMoa0800456","article-title":"Increased mortality after dronedarone therapy for severe heart failure","volume":"358","author":"Kober","year":"2008","journal-title":"N Engl J Med"},{"issue":"527","key":"10.1016\/j.jacc.2026.05.032_bib184","first-page":"e521","article-title":"Dronedarone for the control of ventricular rate in permanent atrial fibrillation: the Efficacy and safety of dRonedArone for the cOntrol of ventricular rate during atrial fibrillation (ERATO) study","volume":"156","author":"Davy","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2026.05.032_bib185","first-page":"345","article-title":"Effect of dronedarone on cardiovascular events in atrial fibrillation","volume":"28","author":"Hohnloser","year":"2009","journal-title":"Rev Port Cardiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib186","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1161\/CIRCEP.114.002339","article-title":"Safety of oral dofetilide for rhythm control of atrial fibrillation and atrial flutter","volume":"8","author":"Abraham","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib187","first-page":"1276","article-title":"Risk of proarrhythmic events in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: a multivariate analysis","volume":"44","author":"Kaufman","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib188","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/S0140-6736(00)03402-4","article-title":"Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial","volume":"356","author":"Kober","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2026.05.032_bib189","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1161\/01.CIR.104.3.292","article-title":"Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (diamond) substudy","volume":"104","author":"Pedersen","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2026.05.032_bib190","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1161\/01.CIR.102.19.2385","article-title":"Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) study","volume":"102","author":"Singh","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2026.05.032_bib191","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1056\/NEJM199909163411201","article-title":"Dofetilide in patients with congestive heart failure and left ventricular dysfunction","volume":"341","author":"Torp-Pedersen","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2026.05.032_bib192","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.4022\/jafib.1805","article-title":"Safety and efficacy of inpatient initiation of dofetilide versus sotalol for atrial fibrillation","volume":"10","author":"Yarlagadda","year":"2017","journal-title":"J Atr Fibrillation"},{"key":"10.1016\/j.jacc.2026.05.032_bib193","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/CIRCULATIONAHA.113.007765","article-title":"Screening for acute IKr block is insufficient to detect torsades de pointes liability: role of late sodium current","volume":"130","author":"Yang","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2026.05.032_bib194","doi-asserted-by":"crossref","first-page":"e214","DOI":"10.1161\/CIR.0000000000000905","article-title":"Drug-induced arrhythmias: a scientific statement from the American Heart Association","volume":"142","author":"Tisdale","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2026.05.032_bib195","series-title":"Tikosyn [package insert]","year":"2025"},{"key":"10.1016\/j.jacc.2026.05.032_bib196","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ijcard.2017.01.157","article-title":"Practice variation in the re-initiation of dofetilide: an observational study","volume":"236","author":"Turagam","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib197","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1001\/jama.2019.10688","article-title":"Catheter ablation compared with drug therapy for atrial fibrillation-reply","volume":"322","author":"Packer","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2026.05.032_bib198","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.2019.0335","article-title":"Effect of catheter ablation vs antiarrhythmic medication on quality of life in patients with atrial fibrillation: the CAPTAF randomized clinical trial","volume":"321","author":"Blomstr\u00f6m-Lundqvist","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2026.05.032_bib199","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1001\/jama.2014.467","article-title":"Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial","volume":"311","author":"Morillo","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2026.05.032_bib200","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1016\/S0735-1097(00)00635-5","article-title":"Prospective randomized comparison of antiarrhythmic therapy versus first- line radiofrequency ablation in patients with atrial flutter","volume":"35","author":"Natale","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib201","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1016\/j.jacc.2007.12.051","article-title":"Pro-B-type natriuretic peptide levels in acute decompensated heart failure","volume":"51","author":"Waldo","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib202","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1161\/01.CIR.0000101684.88679.AB","volume":"108","author":"Wazni","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2026.05.032_bib203","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1540-8167.2008.01275.x","article-title":"Catheter ablation of atrial fibrillation in patients with diabetes mellitus type 2: results from a randomized study comparing pulmonary vein isolation versus antiarrhythmic drug therapy","volume":"20","author":"Forleo","year":"2009","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib204","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1161\/CIRCULATIONAHA.108.772582","article-title":"Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study","volume":"118","author":"Jais","year":"2008","journal-title":"Circulation"},{"issue":"Suppl 1","key":"10.1016\/j.jacc.2026.05.032_bib205","first-page":"S8","article-title":"A randomized clinical trial of the efficacy of radiofrequency catheter ablation and amiodarone in the treatment of symptomatic atrial fibrillation","volume":"86","author":"Krittayaphong","year":"2003","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.jacc.2026.05.032_bib206","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/hrt.2010.207340","article-title":"Radiofrequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction: a randomised controlled trial","volume":"97","author":"MacDonald","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2026.05.032_bib207","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1056\/NEJMoa050955","article-title":"Circumferential pulmonary-vein ablation for chronic atrial fibrillation","volume":"354","author":"Oral","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2026.05.032_bib208","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.jacc.2012.11.064","article-title":"Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial","volume":"61","author":"Packer","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib209","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.2019.0693","article-title":"Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial","volume":"321","author":"Packer","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2026.05.032_bib210","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1161\/CIRCULATIONAHA.121.057095","article-title":"Randomized ablation-based rhythm-control versus rate-control trial in patients with heart failure and atrial fibrillation: results from the RAFT-AF trial","volume":"145","author":"Parkash","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2026.05.032_bib211","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/eurheartj\/ehi583","article-title":"Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation for the Cure of Atrial Fibrillation Study)","volume":"27","author":"Stabile","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2026.05.032_bib212","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/jama.2009.2029","article-title":"Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial","volume":"303","author":"Wilber","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2026.05.032_bib213","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.hrthm.2016.02.005","article-title":"Contemporary utilization and safety outcomes of catheter ablation of atrial flutter in the United States: analysis of 89,638 procedures","volume":"13","author":"Patel","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2026.05.032_bib214","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1161\/CIRCEP.109.871665","article-title":"Long-term outcomes after catheter ablation of cavo-tricuspid isthmus dependent atrial flutter: a meta-analysis","volume":"2","author":"P\u00e9rez","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib215","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1016\/j.jacc.2006.08.037","article-title":"A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF study","volume":"48","author":"Pappone","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib216","doi-asserted-by":"crossref","first-page":"e275","DOI":"10.1016\/j.hrthm.2017.05.012","article-title":"2017 HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation","volume":"14","author":"Calkins","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2026.05.032_bib217","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1161\/CIRCULATIONAHA.109.928903","article-title":"Left atrial appendage: an underrecognized trigger site of atrial fibrillation","volume":"122","author":"Di Biase","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2026.05.032_bib218","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.hrthm.2021.07.066","article-title":"Management and outcomes of atrial fibrillation in 241 healthy children and young adults: revisiting \"lone\" atrial fibrillation: a multi-institutional PACES collaborative study","volume":"18","author":"El Assaad","year":"2021","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2026.05.032_bib219","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/europace\/eum105","article-title":"Inducible supraventricular tachycardias in patients referred for catheter ablation of atrial fibrillation","volume":"9","author":"Katritsis","year":"2007","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2026.05.032_bib220","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.jacc.2005.06.016","article-title":"Predictors of non-pulmonary vein ectopic beats initiating paroxysmal atrial fibrillation: implication for catheter ablation","volume":"46","author":"Lee","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib221","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1046\/j.1460-9592.2001.00969.x","article-title":"Studies on the prevalence of complicated atrial arrhythmias, flutter, and fibrillation in patients with reciprocating supraventricular tachycardia before and after successful catheter ablation","volume":"24","author":"Miyamoto","year":"2001","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib222","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/eurheartj\/eht457","article-title":"Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study)","volume":"35","author":"Mont","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2026.05.032_bib223","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jacc.2007.08.066","article-title":"Inter-relationships of atrial fibrillation and atrial flutter mechanisms and clinical implications","volume":"51","author":"Waldo","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib224","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.amjcard.2021.11.020","article-title":"Catheter ablation for atrial fibrillation in patients \u226430 years of age","volume":"166","author":"Yalin","year":"2022","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib225","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1161\/CIRCULATIONAHA.122.058575","article-title":"Cost-effectiveness of catheter ablation versus antiarrhythmic drug therapy in atrial fibrillation: the CABANA randomized clinical trial","volume":"146","author":"Chew","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2026.05.032_bib226","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1056\/NEJMoa2212540","article-title":"Progression of atrial fibrillation after cryoablation or drug therapy","volume":"388","author":"Andrade","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2026.05.032_bib227","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa2029980","article-title":"Cryoablation or drug therapy for initial treatment of atrial fibrillation","volume":"384","author":"Andrade","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2026.05.032_bib228","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1056\/NEJMoa1113566","article-title":"Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation","volume":"367","author":"Cosedis Nielsen","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2026.05.032_bib229","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1056\/NEJMoa2029554","article-title":"Cryoballoon ablation as initial therapy for atrial fibrillation","volume":"384","author":"Wazni","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2026.05.032_bib230","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1001\/jama.293.21.2634","article-title":"Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial","volume":"293","author":"Wazni","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2026.05.032_bib231","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/europace\/euu188","article-title":"The cost-effectiveness of radiofrequency catheter ablation as first-line treatment for paroxysmal atrial fibrillation: results from a MANTRA-PAF substudy","volume":"17","author":"Aronsson","year":"2015","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2026.05.032_bib232","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ahj.2011.05.008","article-title":"Clinical characteristics of patients with asymptomatic recurrences of atrial fibrillation in the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-Atrial Fibrillation (GISSI-AF) trial","volume":"162","author":"Disertori","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2026.05.032_bib233","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1161\/STROKEAHA.118.021396","article-title":"Progression from paroxysmal to sustained atrial fibrillation is associated with increased adverse events","volume":"49","author":"Ogawa","year":"2018","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2026.05.032_bib234","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.hrthm.2017.01.038","article-title":"Progression of paroxysmal to persistent atrial fibrillation: 10-year follow-up in the Canadian Registry of Atrial Fibrillation","volume":"14","author":"Padfield","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2026.05.032_bib235","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1253\/circj.CJ-13-1272","article-title":"Progression to the persistent form in asymptomatic paroxysmal atrial fibrillation","volume":"78","author":"Senoo","year":"2014","journal-title":"Circ J"},{"key":"10.1016\/j.jacc.2026.05.032_bib236","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/jce.14826","article-title":"Associations of atrial fibrillation progression with clinical risk factors and clinical prognosis: a report from the Chinese Atrial Fibrillation Registry study","volume":"32","author":"Yang","year":"2021","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib237","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1016\/j.jacc.2014.09.053","article-title":"Comparison of radiofrequency catheter ablation of drivers and circumferential pulmonary vein isolation in atrial fibrillation: a noninferiority randomized multicenter RADAR-AF trial","volume":"64","author":"Atienza","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib238","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/j.1540-8167.2011.02051.x","article-title":"Randomized comparison between pulmonary vein antral isolation versus complex fractionated electrogram ablation for paroxysmal atrial fibrillation","volume":"22","author":"Chen","year":"2011","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib239","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/CIRCEP.108.798447","article-title":"Atrial fibrillation ablation strategies for paroxysmal patients: randomized comparison between different techniques","volume":"2","author":"Di Biase","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib240","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1016\/j.jacc.2013.06.053","article-title":"Autonomic denervation added to pulmonary vein isolation for paroxysmal atrial fibrillation: a randomized clinical trial","volume":"62","author":"Katritsis","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib241","first-page":"31","article-title":"'Electrical exclusion' of a critical myocardial mass by extended pulmonary vein antrum isolation for persistent atrial fibrillation treatment","volume":"6","author":"Mamchur","year":"2014","journal-title":"Interv Med Appl Sci"},{"key":"10.1016\/j.jacc.2026.05.032_bib242","first-page":"968","article-title":"Meta-analysis of randomized controlled trials of atrial fibrillation ablation with pulmonary vein isolation versus without","volume":"5","author":"Sau","year":"2019","journal-title":"J Am Coll Cardiol Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib243","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/eurheartj\/ehq041","article-title":"Substrate and trigger ablation for reduction of atrial fibrillation (STAR AF): a randomized, multicentre, international trial","volume":"31","author":"Verma","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2026.05.032_bib244","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.hrthm.2014.03.003","volume":"11","author":"Di Biase","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2026.05.032_bib245","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJMoa1701005","article-title":"Uninterrupted dabigatran versus warfarin for ablation in atrial fibrillation","volume":"376","author":"Calkins","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2026.05.032_bib246","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1093\/eurheartj\/ehv177","article-title":"Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation","volume":"36","author":"Cappato","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2026.05.032_bib247","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1093\/eurheartj\/ehz190","article-title":"Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial","volume":"40","author":"Hohnloser","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2026.05.032_bib248","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1093\/eurheartj\/ehy176","article-title":"Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation","volume":"39","author":"Kirchhof","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2026.05.032_bib249","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/jce.12928","article-title":"Apixaban versus warfarin for the prevention of periprocedural cerebral thromboembolism in atrial fibrillation ablation: multicenter prospective randomized study","volume":"27","author":"Kuwahara","year":"2016","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib250","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.hrthm.2017.09.011","article-title":"An updated meta-analysis of novel oral anticoagulants versus vitamin K antagonists for uninterrupted anticoagulation in atrial fibrillation catheter ablation","volume":"15","author":"Cardoso","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2026.05.032_bib251","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.1994","article-title":"Safety and efficacy of minimally interrupted dabigatran vs uninterrupted warfarin therapy in adults undergoing atrial fibrillation catheter ablation: a randomized clinical trial","volume":"2","author":"Nogami","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacc.2026.05.032_bib252","first-page":"580","article-title":"A prospective randomized trial of apixaban dosing during atrial fibrillation ablation: the AEIOU trial","volume":"4","author":"Reynolds","year":"2018","journal-title":"J Am Coll Cardiol Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib253","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1093\/europace\/euab175","article-title":"Meta-analysis of controlled studies on minimally interrupted vs. continuous use of non-vitamin K antagonist oral anticoagulants in catheter ablation for atrial fibrillation","volume":"23","author":"van Vugt","year":"2021","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2026.05.032_bib254","first-page":"594","article-title":"Atrial fibrillation burden and clinical outcomes in heart failure: the CASTLE-AF trial","volume":"7","author":"Brachmann","year":"2021","journal-title":"J Am Coll Cardiol Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib255","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1161\/CIRCULATIONAHA.121.056323","article-title":"Early rhythm control therapy in patients with atrial fibrillation and heart failure","volume":"144","author":"Rillig","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2026.05.032_bib256","doi-asserted-by":"crossref","first-page":"138","DOI":"10.2459\/01.JCM.0000260841.30415.62","article-title":"Tachycardia-induced cardiomyopathy: mechanisms of heart failure and clinical implications","volume":"8","author":"Calo","year":"2007","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"10.1016\/j.jacc.2026.05.032_bib257","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1161\/01.CIR.0000135472.28234.CC","article-title":"Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia","volume":"110","author":"Nerheim","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2026.05.032_bib258","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.jacc.2015.08.038","article-title":"Arrhythmia-induced cardiomyopathies: mechanisms, recognition, and management","volume":"66","author":"Gopinathannair","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib259","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1707855","article-title":"Catheter ablation for atrial fibrillation with heart failure","volume":"378","author":"Marrouche","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2026.05.032_bib260","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/j.jacc.2017.08.041","article-title":"Catheter ablation versus medical rate control in atrial fibrillation and systolic dysfunction: the CAMERA-MRI study","volume":"70","author":"Prabhu","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib261","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1161\/CIRCULATIONAHA.115.019406","article-title":"Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device: results from the AATAC multicenter randomized trial","volume":"133","author":"Di Biase","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2026.05.032_bib262","doi-asserted-by":"crossref","first-page":"41","DOI":"10.7326\/M18-0992","article-title":"Catheter ablation of atrial fibrillation in patients with heart failure: a meta-analysis of randomized controlled trials","volume":"170","author":"Turagam","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2026.05.032_bib263","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1093\/eurheartj\/ehz443","article-title":"Rhythm control for patients with atrial fibrillation complicated with heart failure in the contemporary era of catheter ablation: a stratified pooled analysis of randomized data","volume":"41","author":"Chen","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2026.05.032_bib264","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1161\/CIRCEP.113.000806","article-title":"A randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure (the CAMTAF trial)","volume":"7","author":"Hunter","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib265","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/j.jacc.2013.01.069","article-title":"A randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure","volume":"61","author":"Jones","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib266","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.119.007731","article-title":"Catheter ablation versus best medical therapy in patients with persistent atrial fibrillation and congestive heart failure: the randomized AMICA trial","volume":"12","author":"Kuck","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib267","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.7150\/ijms.52257","article-title":"Catheter ablation compared with medical therapy for atrial fibrillation with heart failure: a systematic review and meta-analysis of randomized controlled trials","volume":"18","author":"Pan","year":"2021","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.jacc.2026.05.032_bib268","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1161\/CIRCULATIONAHA.114.014058","article-title":"Long-term outcomes of secondary atrial fibrillation in the community: the Framingham Heart Study","volume":"131","author":"Lubitz","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2026.05.032_bib269","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.119.007716","article-title":"Initial precipitants and recurrence of atrial fibrillation","volume":"13","author":"Wang","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib270","first-page":"130","article-title":"Atrial fibrillation detected initially during acute medical illness: a systematic review","volume":"8","author":"McIntyre","year":"2019","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.jacc.2026.05.032_bib271","first-page":"1134","article-title":"The incidence and natural progression of new-onset postoperative atrial fibrillation","volume":"7","author":"Abdelmoneim","year":"2021","journal-title":"J Am Coll Cardiol Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib272","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1111\/jce.15126","article-title":"Atrial fibrillation recurrence and spontaneous conversion to sinus rhythm after cardiac surgery: Insights from 426 patients with continuous rhythm monitoring","volume":"32","author":"Charitos","year":"2021","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2026.05.032_bib273","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/pace.12949","article-title":"Management of new-onset postoperative atrial fibrillation utilizing insertable cardiac monitor technology to observe recurrence of AF (MONITOR-AF)","volume":"39","author":"El-Chami","year":"2016","journal-title":"Pacing Clin Electrophysiol"}],"container-title":["JACC"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073510972606657X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073510972606657X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T19:34:42Z","timestamp":1787081682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073510972606657X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":273,"alternative-id":["S073510972606657X"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2026.05.032","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"2026 AHA\/ACC Clinical Performance and Quality Measures for Patients With Atrial Fibrillation","name":"articletitle","label":"Article Title"},{"value":"JACC","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2026.05.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the American Heart Association, Inc, and the American College of Cardiology Foundation","name":"copyright","label":"Copyright"}]}}